This is a preprint.
CRISPR-GPT for Agentic Automation of Gene Editing Experiments
- PMID: 39463961
- PMCID: PMC11507792
- DOI: 10.1101/2024.04.25.591003
CRISPR-GPT for Agentic Automation of Gene Editing Experiments
Update in
-
CRISPR-GPT for agentic automation of gene-editing experiments.Nat Biomed Eng. 2025 Jul 30. doi: 10.1038/s41551-025-01463-z. Online ahead of print. Nat Biomed Eng. 2025. PMID: 40738974
Abstract
Performing effective gene-editing experiments requires a deep understanding of both the CRISPR technology and the biological system involved. Meanwhile, despite their versatility and promise, Large Language Models (LLMs) often lack domain-specific knowledge and struggle to accurately solve biological design problems. We present CRISPR-GPT, an LLM agent system to automate and enhance CRISPR-based gene-editing design and data analysis. CRISPR-GPT leverages the reasoning capabilities of LLMs for complex task decomposition, decision-making, and interactive human-artificial intelligence (AI) collaboration. This system incorporates domain expertise, retrieval techniques, external tools, and a specialized LLM fine-tuned with open-forum discussions among scientists. CRISPR-GPT assists users in selecting CRISPR systems, experiment planning, designing gRNAs, choosing delivery methods, drafting protocols, designing assays, and analyzing data. We showcase the potential of CRISPR-GPT by knocking-out four genes with CRISPR-Cas12a in a human lung adenocarcinoma cell line and epigenetically activating two genes using CRISPR-dCas9 in human melanoma cell line. CRISPR-GPT enables fully AI-guided gene-editing experiment design and analysis across different modalities, validating its effectiveness as an AI co-pilot in genome engineering.
Publication types
LinkOut - more resources
Full Text Sources